ALNYLAM PHARMACEUTICALS, INC. Income Tax Expense 2008-2025 | ALNY
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is ALNYLAM PHARMACEUTICALS, INC.'s current income tax expense?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual income tax expense for 2025 was $9.4M, a 109.48% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. income tax expense for the quarter ending December 31, 2025 was $-25.3M.
What was ALNYLAM PHARMACEUTICALS, INC.'s income tax expense in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual income tax expense for 2024 was $-99.2M, a 1575.36% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s income tax expense in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual income tax expense for 2023 was $6.7M, a 61.54% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year income tax expense CAGR?
ALNYLAM PHARMACEUTICALS, INC. income tax expense grew at a compound annual growth rate (CAGR) of 28.53% from FY2020 to FY2025, going from $2.7M to $9.4M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.4M | +109.5% | 10-K |
| FY2024 | $-99.2M | -1575.4% | 10-K |
| FY2023 | $6.7M | +61.5% | 10-K |
| FY2022 | $4.2M | +512.2% | 10-K |
| FY2021 | $680,000 | -74.6% | 10-K |
| FY2020 | $2.7M | +210.7% | 10-K |
| FY2019 | $863,000 | +4.9% | 10-K |
| FY2018 | $823,000 | - | 10-K |
| FY2017 | $0 | - | 10-K |
| FY2016 | $0 | - | 10-K |
| FY2015 | $0 | +100.0% | 10-K |
| FY2014 | $-40.2M | -1392.0% | 10-K |
| FY2013 | $-2.7M | +74.5% | 10-K |
| FY2012 | $-10.6M | - | 10-K |
| FY2011 | $0 | -100.0% | 10-K |
| FY2010 | $514,000 | -11.7% | 10-K |
| FY2009 | $582,000 | -19.1% | 10-K |
| FY2008 | $719,000 | - | 10-K |